These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 34648194)
1. TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain. Munot P; McCrea N; Torelli S; Manzur A; Sewry C; Chambers D; Feng L; Ala P; Zaharieva I; Ragge N; Roper H; Marton T; Cox P; Milev MP; Liang WC; Maruyama S; Nishino I; Sacher M; Phadke R; Muntoni F Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12771. PubMed ID: 34648194 [TBL] [Abstract][Full Text] [Related]
2. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy. Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340 [TBL] [Abstract][Full Text] [Related]
3. TRAPPC11-CDG muscular dystrophy: Review of 54 cases including a novel patient. Corona-Rivera JR; Martínez-Duncker I; Morava E; Ranatunga W; Salinas-Marin R; González-Jaimes AM; Castillo-Reyes KA; Peña-Padilla C; Bobadilla-Morales L; Corona-Rivera A; Orozco-Vela M; Brukman-Jiménez SA Mol Genet Metab; 2024 May; 142(1):108469. PubMed ID: 38564972 [TBL] [Abstract][Full Text] [Related]
4. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029 [TBL] [Abstract][Full Text] [Related]
6. Muscular dystrophy: central nervous system alpha-dystroglycan glycosylation defects and brain malformation. Fagiolari G; Cappellini A; Cagliani R; Prelle A; Lucchini V; Fortunato F; Locatelli F; Crugnola V; Comi GP; Bresolin N; Moggio M; Lamperti C J Child Neurol; 2010 Mar; 25(3):312-20. PubMed ID: 19633331 [TBL] [Abstract][Full Text] [Related]
7. Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular dystrophy and myopathy with movement disorder and intellectual disability. Bögershausen N; Shahrzad N; Chong JX; von Kleist-Retzow JC; Stanga D; Li Y; Bernier FP; Loucks CM; Wirth R; Puffenberger EG; Hegele RA; Schreml J; Lapointe G; Keupp K; Brett CL; Anderson R; Hahn A; Innes AM; Suchowersky O; Mets MB; Nürnberg G; McLeod DR; Thiele H; Waggoner D; Altmüller J; Boycott KM; Schoser B; Nürnberg P; Ober C; Heller R; Parboosingh JS; Wollnik B; Sacher M; Lamont RE Am J Hum Genet; 2013 Jul; 93(1):181-90. PubMed ID: 23830518 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Jimenez-Mallebrera C; Torelli S; Feng L; Kim J; Godfrey C; Clement E; Mein R; Abbs S; Brown SC; Campbell KP; Kröger S; Talim B; Topaloglu H; Quinlivan R; Roper H; Childs AM; Kinali M; Sewry CA; Muntoni F Brain Pathol; 2009 Oct; 19(4):596-611. PubMed ID: 18691338 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034 [TBL] [Abstract][Full Text] [Related]
10. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern. Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643 [TBL] [Abstract][Full Text] [Related]
11. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512 [TBL] [Abstract][Full Text] [Related]
13. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638 [TBL] [Abstract][Full Text] [Related]
14. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726 [TBL] [Abstract][Full Text] [Related]
15. The role of defective glycosylation in congenital muscular dystrophy. Schachter H; Vajsar J; Zhang W Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394 [TBL] [Abstract][Full Text] [Related]
16. Congenital muscular dystrophy with muscle inflammation alpha dystroglycan glycosylation defect and no mutation in FKRP gene. Lamperti C; Cagliani R; Ciscato P; Moroni I; Viri M; Romeo A; Fagiolari G; Prelle A; Comi GP; Bresolin N; Moggio M J Neurol Sci; 2006 Apr; 243(1-2):47-51. PubMed ID: 16386759 [TBL] [Abstract][Full Text] [Related]
17. Congenital muscular dystrophy with fatty liver and infantile-onset cataract caused by TRAPPC11 mutations: broadening of the phenotype. Liang WC; Zhu W; Mitsuhashi S; Noguchi S; Sacher M; Ogawa M; Shih HH; Jong YJ; Nishino I Skelet Muscle; 2015; 5():29. PubMed ID: 26322222 [TBL] [Abstract][Full Text] [Related]
18. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea. Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061 [TBL] [Abstract][Full Text] [Related]
19. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957 [TBL] [Abstract][Full Text] [Related]
20. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]